Themis Medicare Share Price

Themis Medicare Share Price

NSE: THEMISMED
|
Pharmaceuticals
|
S Cap
₹ 103.96
-₹4.68 (-4.31%)
1D
Last updated 13 Aug, 2026, 15:50 IST

Themis Medicare Share Price Today

As of 14 Aug 2026, Themis Medicare share price is ₹103.96. The stock opened at ₹108.45, compared to its previous close of ₹108.64. During today's trading session, Themis Medicare share price moved in the range of ₹102.28 to ₹116.75, with an average price of ₹109.52 for the day. Looking at its last 52-week, the stock has touched a low of ₹64.95 and a high of ₹148.00. On the performance front, Themis Medicare share price has increased by 14.46% over the last six months and is down 1.24% on a year-on-year basis.

₹102.28
4.31% down today
₹116.75
1D LOW
1D HIGH

Themis Medicare Returns Calculator

Circuit
L
H
₹86.92
₹130.36
52-week
L
H
₹64.95
₹148.00

About Themis Medicare

Themis Medicare Share Price
ISIN
INE083B01024
Sector Market Cap
₹ 991.46 Cr

Themis Medicare Limited is a research-based pharmaceutical company, which is engaged in the manufacturing of pharmaceutical products, especially in formulation and active pharmaceutical ingredients (API) activity. The Company operates through one segment: Pharmaceuticals. The Company manufactures therapeutic pharma products, differential healthcare products, and APIs based in India. The Company specializes in manufacturing a range of products for application areas like pain management, critical care and anti-infectives. Its analgesic and anti-inflammatory products include Aquadol Tpm Gel, Etojet 90 10'S, Etojet 120 10'S, Etojet Mr Tablets 10'S, Etojet XP Gel, Themidol-P Tab 10's, Dhoom, Aquadol inj, Dyloaqua inj, Joydol -P, Joydol -SP, Joydol -TH, and Nimujet Gel. Its Analgesics products include Anemol, Tazowin, Themidol, Themidol. Its Anesthesia products include Bupicaine 0.25%, Ketmin 2 Vial, Ketmin 5, Ropicaine 2, Themicaine 2%, and more.

Themis Medicare Financial Highlights

  • Revenue: Themis Medicare reported revenue of ₹351.60 crore in FY26 vs ₹410.18 crore in FY25. It showed a decrease of 14.28% on a yearly basis.
  • Operating Profit: Themis Medicare reported an operating profit of ₹1.93 crore in FY26 vs ₹39.67 crore in FY25. It showed a decrease of 95.13% on a year-on-year basis.
  • Net Profit: Themis Medicare reported a net profit of ₹1.14 crore in FY26 vs ₹29.83 crore in FY25. It showed a decrease of 96.18% on a yearly basis.

Themis Medicare Quarterly Result Highlights

  • Themis Medicare reported revenue of ₹80.20 crore in Mar 2026, compared with ₹91.41 crore in Dec 2025, representing a decrease of 12.26% on a quarter-on-quarter (QoQ) basis.
  • Themis Medicare reported an operating profit of ₹9.06 crore in Mar 2026, compared with ₹10.39 crore in Dec 2025, representing a decrease of 12.80% on a quarter-on-quarter (QoQ) basis.
  • Themis Medicare reported a profit of ₹8.89 crore in Mar 2026, compared with ₹10.09 crore in Dec 2025, reflecting a decrease of 11.89% on a QoQ basis.
  • The earnings per share (EPS) of Themis Medicare stood at ₹3.24 during Mar 2026.
Know more
Promoters
67.11%
FII
0.01%
Other DII
0.01%
Retail and other
32.87%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20250.06%
Dec 20250.05%
Mar 20260.11%
Jun 20260.01%
Mkt Cap Cr
991.46
P/E
23.96
P/B
2.62
ROE
0.42%
D/E
0.33
ROCE
2.70%
Div. Yield
0.48%
EPS(TTM)
-1.54
Turnover
0.68
EV/EBITDA
47.58
Net Margin
0.00%
Op. Margin
0.00%
ROA
0.19%
Quick Ratio
0.00
Curr. Ratio
3.47
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Themis Medicare has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Themis Medicare appears overvalued compared to its peers
Step 1 of 5
Earnings
Very Poor
Themis Medicare revenue, operating profits and net profits have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,64,271.0038.325.5613.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,26,843.0077.5513.5315.32%0.0019.56%629.490.35%0.5598.19
Torrent Pharmaceuticals1,86,000.0086.2722.1225.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,20,099.0026.154.4318.59%0.3117.35%237.300.08%0.3335.38
Cipla1,18,027.0035.183.4311.27%0.0014.95%423.360.89%0.4543.52
Lupin1,03,549.0018.654.6123.76%0.0424.88%659.050.79%0.57129.18
Mankind Pharma1,00,137.0048.436.1411.74%0.3413.13%397.020.04%0.4449.37
Dr. Reddy's Laboratories1,00,073.0031.442.6311.07%0.1812.54%377.960.67%0.4138.68
Laurus Labs99,474.2091.2318.7716.77%0.4016.14%97.200.11%0.6713.72
Aurobindo Pharma96,700.6026.062.559.25%0.1911.76%391.140.24%0.3841.58

Themis Medicare Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹405.51₹381.76₹354.32₹394.61
Other Income₹4.67₹4.76₹11.50₹6.54
Total Revenue₹410.18₹386.52₹365.83₹401.16
Total Expenses₹376.43₹351.88₹306.93₹317.23
Profit Before Tax₹39.67₹53.44₹72.51₹95.26
Tax₹9.84₹9.92₹15.61₹22.38
Profit After Tax₹29.83₹43.52₹56.90₹72.88
EPS - Basic₹3.24₹4.73₹6.18₹79.22
EPS - Diluted₹3.24₹4.72₹6.17₹79.07

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹39.67₹53.44₹72.51₹95.26
Income before WC changes₹50.57₹51.97₹72.54₹95.02
Change in Assets-₹14.31-₹31.83-₹56.66-₹28.96
Change in Liabilities₹9.20₹10.91₹16.36-₹13.59
Change in WC-₹5.11-₹20.92-₹40.30-₹42.55
Cash flow from Operations₹34.71₹22.09₹16.09₹34.39
Cash flow from Investing-₹12.17-₹15.95-₹23.96-₹15.59
Cash flow from Financing-₹25.90-₹8.77₹0.14-₹17.55
Total Cash Flow-₹3.36-₹2.62-₹7.73₹1.26
Cash (Start of the year)₹9.92₹12.55₹20.28₹19.02
Cash (End of the year)₹6.56₹9.92₹12.55₹20.28

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹284.17₹273.25₹249.43₹213.62
Current Assets₹303.87₹293.17₹264.53₹214.16
Total Assets₹588.03₹566.42₹513.96₹427.78
Current Liabilities₹156.12₹154.58₹139.13₹109.52
Net Current Asset₹147.74₹138.58₹125.40₹104.64
Non-Current Liabilities₹29.31₹34.17₹35.39₹30.77
Equity Capital₹402.60₹377.67₹339.44₹287.49
Total Equity & Liabilities₹588.03₹566.42₹513.96₹427.78

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹405.51₹381.76₹354.32₹394.61
Other Income₹4.67₹4.76₹11.50₹6.54
Total Revenue₹410.18₹386.52₹365.83₹401.16
Total Expenses₹376.42₹351.85₹306.92₹317.22
Profit Before Tax₹33.76₹34.67₹58.91₹83.94
Tax₹9.84₹9.92₹15.61₹22.38
Profit After Tax₹23.92₹24.75₹43.29₹61.56
EPS - Basic₹2.60₹2.69₹4.70₹66.91
EPS - Diluted₹2.59₹2.68₹4.70₹66.78

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹33.76₹34.67₹58.91₹83.94
Income before WC changes₹50.58₹51.99₹72.57₹95.04
Change in Assets-₹14.32-₹31.89-₹56.68-₹28.98
Change in Liabilities₹9.20₹10.91₹16.34-₹13.59
Change in WC-₹5.12-₹20.99-₹40.34-₹42.57
Cash flow from Operations₹34.71₹22.04₹16.07₹34.39
Cash flow from Investing-₹12.17-₹15.96-₹23.96-₹15.58
Cash flow from Financing-₹25.90-₹8.77₹0.14-₹17.55
Total Cash Flow-₹3.36-₹2.68-₹7.75₹1.26
Cash (Start of the year)₹9.83₹12.51₹20.27₹19.00
Cash (End of the year)₹6.47₹9.83₹12.51₹20.27

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹200.50₹195.52₹190.49₹168.32
Current Assets₹305.15₹294.44₹265.80₹215.42
Total Assets₹505.65₹489.97₹456.29₹383.74
Current Liabilities₹156.06₹152.92₹139.07₹109.48
Net Current Asset₹149.09₹141.52₹126.72₹105.94
Non-Current Liabilities₹29.31₹35.77₹35.39₹30.77
Equity Capital₹320.29₹301.28₹281.83₹243.48
Total Equity & Liabilities₹505.65₹489.97₹456.29₹383.74
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
103.96
3500
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 3500
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
3
Bullish
4
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
42.05
Neutral
ATR (14)
6.03
Neutral
STOCH(9,6)
10.76
Bullish
STOCH RSI (14)
6.6
Bullish
ADX(9)
16.7
Bullish
UO(9)
32.24
Neutral
ROC(12)
-1.72
Bearish
WillR(14)
-89.24
Bullish
Period
Simple value
Exponential vaue
5D
109.04
108.34
10D
110.17
109.32
20D
109.41
109.95
50D
110.25
108.52
100D
100.82
104.26
Volume trend — traded volume by day
13 Aug6L
12 Aug0L
11 Aug1L
10 Aug1L
7 Aug0L
Average1L
Compare against other stocks
Themis Medicare Share Price
Themis Medicare
Pharmaceuticals
Add Stock
Add Another

Themis Medicare Share Price FAQs